Social Finance Announces New Career Impact Bond with Clinical Research Fastrack to Expand Access to Clinical Research Job Training, Economic Mobility
Retrieved on:
Wednesday, July 6, 2022
Social finance, Michael & Susan Dell Foundation, Science, Research, Cancer, Industry, Parkinson's disease, Refugee, Boston, Blue Haven Initiative, The Boston Foundation, Student Bill of Rights, Parkinson's disease clinical research, Regulation D, Chronic Respiratory Disease, COVID-19, Obesity, Housing, Liver disease, Person, Investment, Degenerative disease, Information technology, Bill Ackman, Diabetes, Education, Alzheimer's disease, CEO, Greater Boston, First Ever, Combined, Partnership, Clinical research, W. K. Kellogg Foundation, Rule, Health, MacArthur Foundation, MFS Investment Management, Multimedia, View, Sepsis, Employment, Neoplasm, Michael, Entrepreneurship, Program, Arthritis, Management, Medicine, Tutoring
BOSTON and SCOTTSDALE, Ariz., July 6, 2022 /PRNewswire/ -- Today, Social Finance announced its latest Career Impact Bond, a $5 million partnership with Clinical Research Fastrack to help people facing barriers to employment, including immigrants and refugees with impressive medical or science degrees earned outside of the U.S., find careers within the growing clinical research industry.
Key Points:
- "We're excited to partner with Clinical Research Fastrack to train clinical research professionals who help bring new life-saving treatments to market," Social Finance CEO and Co-Founder Tracy Palandjian said.
- "It's exciting to collaborate with Social Finance on a program that will diversify and strengthen the clinical research industry," Clinical Research Fastrack Co-Founder and CEO David Silberman said.
- Clinical Research Fastrack was founded in 2016 to improve the quality and progress of clinical research by educating and empowering new research professionals.
- Clinical Research Fastrack trains aspiring Clinical Research professionals and connects them with leading research organizations to elevate the efficacy of clinical trials.